Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. - Wikidata - awgldk - TriplyDB

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.

http://www.wikidata.org/entity/Q37356739

about

Weight reduction for non-alcoholic fatty liver disease Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings Lifestyle interventions for the treatment of non-alcoholic fatty liver disease Role of mitochondria in nonalcoholic fatty liver disease Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis Treatment of nonalcoholic fatty liver disease: role of AMPK.Clinical advances in pediatric nonalcoholic fatty liver disease.Magnetic resonance spectroscopy studies of human metabolism.Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial.Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans Determinants of serum-induced SIRT1 expression in older men: the CHAMP study.Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity Hyper- and hypo- nutrition studies of the hepatic transcriptome and epigenome suggest that PPARα regulates anaerobic glycolysis NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging.The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial The GH/IGF-1 axis in ageing and longevity Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Role of diet and lifestyle changes in nonalcoholic fatty liver disease Effect of a multifaceted, church-based wellness program on metabolic syndrome in 41 overweight or obese congregants.Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?A complications-based clinical staging of obesity to guide treatment modality and intensity.Feasibility of assessing liver lipid by proton magnetic resonance spectroscopy in healthy normal and overweight prepubertal children Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity.Caloric restriction: powerful protection for the aging heart and vasculature.Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver.Effect of caloric restriction and AMPK activation on hepatic nuclear receptor, biotransformation enzyme, and transporter expression in lean and obese mice.Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.Calorie restriction: what recent results suggest for the future of ageing research Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue.The role of metformin in the management of NAFLD Calorie restriction for optimal cardiovascular aging: the weight of evidence Diet and aging.Quantitative trait loci affecting liver fat content in mice.An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).

P2860

Q24236500-BD730D60-812F-410B-968A-F85501D7D786 Q24634601-03C295A3-E8FF-47F9-BE05-3561C461903D Q24647295-06B7E8D4-0A8C-4929-A644-8B41D239AAF0 Q26822441-2A80B464-4F47-40E7-B3AF-0B13E5FBA874 Q26862945-DB38EE83-597A-4AA5-A83B-156FFF51CCF1 Q27028142-E1F6F6D2-B546-481B-8487-FCF71F9CD4AD Q28539815-ED59C93B-204C-4C6B-AE97-D2AC60F95643 Q30248230-2BB41C35-C275-4FFE-89F3-DA761EBB2D78 Q30357622-5CEAEB7C-7EE6-4E74-B71E-7BFDAE31C10C Q30467992-E01A6B5A-5EE8-462A-AAF3-3B2C5EEBEDFC Q30496725-067652FA-49E5-4E66-80C3-49B71B6672B7 Q30505282-F185CE21-014F-44B4-ABCC-5A67CB699411 Q32774312-4BE3020E-2C0C-4DEE-AA70-4393F67AF424 Q33557923-A71402CB-BD12-4C8C-B472-729E6A0367B9 Q33594330-CB7D7C9C-77DE-41BF-A4EF-6393E81AA8F4 Q33670304-A45A5858-0BE8-4402-A8BB-C9B9FE5E9177 Q33754800-7458AF65-FC40-49B4-B817-13D98DA81AFB Q33779662-4A40652F-E365-4F2C-B22D-DA8BCA3D2AA5 Q33810525-B4071D59-C3A2-448A-9935-B459311650CE Q33817029-388BF006-E1EC-4129-B7AC-0FAC111A34C1 Q33855157-A82F04EE-2845-49B5-980F-C19405C5A31C Q33948329-A8F496E8-568C-4F8C-9593-DC6186B2DF07 Q33982776-2D209A45-0896-4902-AAD5-C16C7B7D5056 Q34008688-73B3AD9B-F7D9-4FC2-849F-ADC2FFEE2227 Q34070626-A9133B55-685B-4C67-8070-3028ADE731E3 Q34113914-73D55230-7A7A-44BE-8AA8-1202EEB27698 Q34197772-9E59E684-CF09-4D5A-90C4-6C768AB8AC9F Q34207941-E8A7772F-CBDA-4C6B-B0ED-5BF0FDBB2A3C Q34389687-64A578FF-E0DF-4A93-9C62-10BF0133C80D Q34478741-A6DEC086-900D-4C8E-B851-4C90736218FE Q34522557-8E5E9D16-7377-4D46-BC54-33051DA2E7F3 Q34647400-50D1F3B6-C2B3-4275-B569-937AEB23BA30 Q34776579-48DB8728-0BC5-4438-819F-EDE0D0567F5A Q35101309-2FF6B034-BB51-40AA-B389-C51CCCD86961 Q35404761-D3E771AB-17DA-4C52-99F5-8107018DD300 Q35614956-27532F41-42AB-4DC1-BD33-7FF98D7D0BEE Q36069412-37D7E295-2D49-4AB0-871C-AE316C3E5DDA Q36184207-1AC61AA5-90DC-4C72-9E22-020BCCD974EB Q36196049-5D4F35FC-B164-43A3-A81D-F368D476BC4C Q36328050-E60D5C50-C6DE-4AE9-9665-36DCEAA0CE2C

P2860

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.

http://www.wikidata.org/entity/Q37356739

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of 6-month calorie rest ...... and markers of liver function.

@en

Effect of 6-month calorie rest ...... and markers of liver function.

@nl

type

label

Effect of 6-month calorie rest ...... and markers of liver function.

@en

Effect of 6-month calorie rest ...... and markers of liver function.

@nl

prefLabel

Effect of 6-month calorie rest ...... and markers of liver function.

@en

Effect of 6-month calorie rest ...... and markers of liver function.

@nl

P1433

Q37356739-FF82271D-4602-4F87-8725-1B1CA8CE5227

P1476

Q37356739-025ADA7F-CAD6-4964-832E-3279F34D625E

P2093

Q37356739-0C69A7A5-D6D6-442C-9F81-BE903E1675C2

Q37356739-2F7E8AC3-364C-4FD3-914A-6F8CF31C1B22

Q37356739-31646B90-1CCD-46AB-9876-0585D5121E5C

Q37356739-3F005DDB-0372-43B9-B723-3EDF02A1E72C

Q37356739-4125C0F2-2790-47D6-9610-038DFA931ECE

Q37356739-8C1E69A1-F017-4B46-9357-987C998B39C9

Q37356739-DC9C7999-CF57-48DE-90D4-5FCF97454C7F

Q37356739-E451A96C-2E9E-49EB-A057-2D0FF2067DB2

Q37356739-FE6FD7C2-0FE8-4EE5-9C1A-03227C6D105B

Q37356739-FEB1257C-2731-4D84-9DDC-5D5176B58E21

P2860

Q37356739-0190D9C8-431A-435A-B9B2-3D710457B635

Q37356739-0E53C8FD-F0AD-4564-9F47-1DACE1AED2AA

Q37356739-113C381B-1F16-4310-A98D-09433D863516

Q37356739-139D51D9-8658-4ED7-8CF6-69D921B6C421

Q37356739-2144F0D1-6A09-4465-9B88-220907FFB05C

Q37356739-2489BB27-7BB4-4EFC-9BBF-940D06AAFFA8

Q37356739-31D273F4-6001-4B19-B831-B81475B311D7

Q37356739-3DA12353-486C-40AE-BF66-22086250AD72

Q37356739-4502653D-B1EC-49FB-96B1-913DDABCBF7A

Q37356739-46C53099-16E8-4658-B58C-BF891C2B28EC

P304

Q37356739-84C78B3B-DE1D-435B-8A57-E4A30D43CE52

P31

Q37356739-A01820D4-1F49-4E4A-804F-81AB82D380C0

P356

Q37356739-34A6C850-3976-44B7-9F66-95FFFB08F05D

P433

Q37356739-44BDE4AD-C5CB-41D6-A6D1-46B79165C3EB

P478

Q37356739-47E22F67-48D3-4609-9F1F-42FCC70DB22A

P50

Q37356739-5B5AA447-6E33-42C1-9C41-57C2E360B912

Q37356739-A4E590D9-ABE9-476D-9436-7A5BEFDCCED0

P577

Q37356739-29A5DA39-A67F-4472-A42B-ADDC5D77D5BB

P5875

Q37356739-DA3069EB-8C54-429E-ADDC-A40B548B1910

P698

Q37356739-32A1E2AC-3A5C-4896-B7B4-EADE7B3CC805

P932

Q37356739-988CA03F-369F-44F4-9980-DD2DF4B8BD3F

P356

P1433

P1476

Effect of 6-month calorie rest ...... and markers of liver function.

@en

P2093

Anthony J Alfonso

http://www.w3.org/2001/XMLSchema#string

Bradley R Newcomer

http://www.w3.org/2001/XMLSchema#string

D Enette Larson-Meyer

http://www.w3.org/2001/XMLSchema#string

Donald A Williamson

http://www.w3.org/2001/XMLSchema#string

Jennifer C Rood

http://www.w3.org/2001/XMLSchema#string

Julia Volaufova

http://www.w3.org/2001/XMLSchema#string

Leonie K Heilbronn

http://www.w3.org/2001/XMLSchema#string

Michael Lefevre

http://www.w3.org/2001/XMLSchema#string

Pennington CALERIE Team

http://www.w3.org/2001/XMLSchema#string

Steven R Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Nonalcoholic fatty liver disease

Cellular mechanisms of insulin resistance

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

P304

1355-1362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/OBY.2008.201

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Pennington CALERIE Team

P577

2008-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5432006

http://www.w3.org/2001/XMLSchema#string

P698

18421281

http://www.w3.org/2001/XMLSchema#string

P932

2748341

http://www.w3.org/2001/XMLSchema#string